The binding of plasminogen activator inhibitor-1 (PAI-1) to serine proteinases, such as tissue-type plasminogen activator (tPA) and urokinase-type plasminogen activator (uPA), is mediated by the exosite interactions between the surface-exposed VR1, or 37-loop, of the proteinase and the distal reactive center loop (RCL) of PAI-1. Although the contribution of such interactions to the inhibitory activity of PAI-1 has been established, the specific mechanistic steps affected by interactions at the distal RCL remain unknown. We have used protein engineering, stopped-flow fluorimetry, and rapid acid quenching techniques to elucidate the role of exosite interactions in the neutralization of tPA, uPA, and β-trypsin by PAI-1. Alanine substitutions at the distal P4' (Glu-350) and P5' (Glu-351) residues of PAI-1 reduced the rates of Michaelis complex formation (k assoc ) and overall inhibition (k app ) with tPA by 13.4-fold and 4.7-fold, respectively, while the rate of loop insertion or final acyl-enzyme formation (k lim ) increased by 3.3-fold. The effects of double mutations on k assoc , k lim , and k app were small with uPA and nonexistent with β-trypsin. We provide the first kinetic evidence that the removal of exosite interactions significantly alters the formation of the non-covalent Michaelis complex, facilitating the release of the primed side of the distal loop from the active-site pocket of tPA and the subsequent insertion of the cleaved reactive center loop into β-sheet A. Moreover, mutational analysis indicates that the P5' residue contributes more to the mechanism of tPA inhibition, notably by promoting the formation of a final Michaelis complex.
INTRODUCTION
Plasminogen activator inhibitor-1 (PAI-1) 1 functions as the primary regulator of the fibrinolytic system by inhibiting the conversion of plasminogen into plasmin via its action on tissue-type plasminogen activator (tPA) and urokinase-type plasminogen activator (uPA) (1) .
This inhibitor also plays a vital role in other physiological processes, including tumor invasion and tissue remodeling (2) . PAI-1 belongs to the serpin (serine protease inhibitor) superfamily, which shares several unique structural features, including a 5-stranded β-sheet motif and a flexible reactive center loop (RCL). The conformational changes associated with these structures have been linked to the inhibitory function of PAI-1 (3) (4) (5) (6) (7) (8) (9) . Notably, the mechanism of inhibition depends on the structural changes accompanying the S (stressed) to R (relaxed)
transition that results in complete insertion of the N-terminal (proximal) part of the RCL into β-sheet A as an additional β-strand, s4A. The proteinase, tethered by a covalent bond with the P1 residue of the serpin, is displaced from the initial docking site to the opposite end of the serpin molecule, separating the P1' and P1 residues by ~70 Å (10) (11) (12) . This mechanism efficiently distorts and inactivates the catalytic triad of the proteinase, stabilizing the serpin-proteinase complex at the acyl-enzyme intermediate stage.
Unique to the PAI-1 inhibitory mechanism are the exosite interactions between the surface-exposed variable region-1 (VR1) or 37-loop of tPA and the distal RCL of PAI-1 (13, 14) .
These interactions are believed to facilitate the rate of formation of Michaelis complex (tPA•PAI-1), although direct evidence for this hypothesis is still lacking (15) (16) (17) . Several studies have demonstrated the importance of positively charged residues on the VR1 of tPA in the efficient inhibitory activity of PAI-1 (14) (15) (16) (17) . This loop (residues 294-304: FAKHRRSPGER) was partially disordered in the three crystal structures of the catalytic domain of human tPA, by guest on January 28, 2018 http://www.jbc.org/ Downloaded from 4 suggesting some degree of flexibility, and was identified as the site of initial contact with the RCL of serpins (13, 18, 19) . Inspection of the amino acid sequence of PAI-1 indicates a small stretch of amino acids (residues 350-355: EEIIMD) in the RCL that contains three negatively charged residues. This region of PAI-1 could provide the complementary side chains necessary to interact with the positively charged VR1 of tPA, thereby enhancing Michaelis complex formation via electrostatic effects (15, 17) . Moreover, a salt bridge interaction between the Arg-304 of tPA and the Glu-350 of PAI-1 has been proposed on the basis of a model, using the X-ray crystal structure of a non-covalent BPTI-trypsin complex (15) . However, charge reversals of the Glu residues (E350R and E351R) at the distal RCL of PAI-1 only decreased the inhibitory activity against tPA by an order of magnitude compared to the two orders of magnitude change afforded by a similar charge reversal on tPA (i.e., R304E), suggesting that the proposed salt bridge interaction is not the primary determinant of proteinase inhibition (17).
Scheme 1 illustrates the proposed model of the suicide substrate mechanism for tPA inhibition by PAI-1 (10, (20) (21) (22) . In this scheme, a non-covalent Michaelis complex (EI) is formed during the initial encounter (k 1 /k -1 ) of the proteinase (E) with its cognate inhibitor (I).
This is followed by a reversible acylation step (k 2 /k -2 ) that generates an acyl-enzyme intermediate (20) .
In the present studies, we clearly demonstrate that the distal reactive loop residues of PAI-1, namely P4' (Glu-350) and P5' (Glu-351), are both important to the initial binding step of PAI-1 (Scheme 1), facilitating the fast rate of Michaelis complex formation (k assoc ). Alanine substitutions at these residues significantly reduced k assoc by 13.4-fold. Consequently, the ratelimiting displacement of the distal loop (k 3 /k -3 ) is not hindered by a strong exosite interaction, thereby increasing the limiting rate for loop insertion (k lim ) by 3.3-fold. This enhancement is presumably due to a destabilized interaction of the distal reactive loop with tPA. Analysis of the contributions of the distal loop residues to the individual steps of the inhibitory mechanism suggests that the P5' residue is the primary residue involved in the exosite interactions with tPA.
This residue, however, contributes less to the mechanism of uPA inhibition. Together, these results indicate that the difference in the inhibitory activity of PAI-1 toward tPA and uPA are due, in part, to the extent of the exosite interactions with these proteinases. The nucleotides that deviate from the wild-type cDNA sequence are underlined. Mutations were validated by DNA sequencing of the entire PAI-1 gene. All mutant and wild-type constructs were expressed in the E. coli strain BL21(DE3)pLysS and purified as previously described (22, 26) . Labeling of single Cys-containing PAI-1 variants (i.e., P9C, E350A/P9C, E351A/P9C, and E350A/E351A/P9C) with IANBD (Molecular Probes) were performed as described, with labeling efficiencies in the range of 1.0-1.3 mol of NBD/mol of PAI-1 variant (27) . Any latent PAI-1 that was generated from the labeling reaction was separated from its active counterpart by chromatography on immobilized β-anhydrotrypsin as described (23) . The concentrations of recombinant PAI-1 variants were measured at 280 nm, using an absorption coefficient of 0.93 mL mg -1 cm -1 and molecular weight (M r ) of 43,000 (26, 28) . Activity of each labeled PAI-1 variant was assessed by formation of a covalent complex with a 2-fold molar excess of proteinase and non-reducing SDS-PAGE analysis (22, 29 were determined by a competitive kinetic method with the appropriate chromogenic substrates as previously described (20) (21) (22) . Reactions were performed under pseudo-first-order conditions, using the following concentrations: 40-80 nM for PAI-1 variants and 4-8 nM for proteinases.
EXPERIMENTAL PROCEDURES

Chemicals and Reagents
The progress curves for inhibition were monitored at 405 nm and fitted to a single exponential function with linear component to obtain the pseudo-first-order rate constant, k obs . The secondorder rate constant, k app , was calculated for each proteinase:PAI-1 pair as described (22) For the reaction with elastase, PAI-1 was incubated with 0.04 µM proteinase for 1 hr prior to data acquisition. Fluorescence enhancements were measured as previously described (27) .
Stopped-Flow Kinetics of P9-NBD-Labeled PAI-1  Stopped-flow fluorimetry was
performed on an Applied Photophysics SX.18MV instrument with a thermostated syringe chamber. The fluorescence change accompanying the reaction of NBD-labeled PAI-1 variants with at least a 5-fold molar excess of each proteinase was monitored at 480 nm, using an 9 emission filter (Oriel 51300) with a cutoff below 515 nm (21, 22, 27) . As found previously, all stopped-flow traces fit best to a double exponential function, yielding pseudo-first-order rate constants k obs1 and k obs2 (27) . Of the two rate constants, the faster component (k obs1 ) yielded the major fluorescence change and was analyzed. The minor contribution of k obs2 to the fluorescence change has been accounted for and discussed elsewhere (21, 27) . The plot of k obs vs. proteinase concentration was fitted to an equation that assumes a two-step binding mechanism and is best described by a rectangular hyperbola function: 
Limiting Rate Constant for Formation of the Inhibited Serpin-Proteinase Complex 
The rate of formation of the stable tPA•PAI-1 complex was determined by continuous-flow rapid acid quenching as previously described (20, 22) . Saturating conditions were chosen to monitor single turnover of PAI-1 by the enzyme. In this case, 3 µM tPA was reacted with 1 µM E350A/E351A PAI-1 and the reaction products were analyzed as described (20) . The limiting rate constant for the formation of the final inhibited complex was determined by fitting the reaction progress curve to a nonlinear function describing a first-order reaction.
RESULTS
Inhibitory Properties of Exosite PAI-1 Variants 
To evaluate the effects of site-directed mutations on the ability of PAI-1 to form stable serpin-proteinase complexes, the single (E350A and E351A) and double (E350A/E351A) exosite variants were reacted with a 2-fold molar excess of each proteinase, followed by SDS-PAGE analysis. Figure 1 shows that each PAI-1 by guest on January 28, 2018
http://www.jbc.org/ Downloaded from variant is just as capable as wtPAI-1 in forming SDS-stable complexes with tPA and uPA, as well as β-trypsin (data not shown). In addition, the SI values for tPA, uPA, and β-trypsin were not significantly different from those of control wtPAI-1 reactions (Table 1) . Although the exosite variants appeared to be functional as proteinase inhibitors, the point mutations reduced the apparent second-order rate constant (k app ) for tPA inhibition (Table 1) . In comparison to wtPAI-1, the E351A and E350A/E351A variants reduced the k app by 4-fold and 5-fold, respectively, but the E350A substitution reduced the k app by only 2-fold. As indicated in Table 1, the exosite substitutions at the P4' and P5' residues did not dramatically change the k app values for the inhibition of uPA and had no effect on the inhibition of β-trypsin. Taken together, the data suggest that the role of the P4' and P5' residues in the proteinase inhibition is to increase the specificity for tPA, while having little or no effect on PAI-1 inhibitory activity with uPA and β-trypsin, respectively.
Association Rate Constants for Exosite Mutant PAI-1:Proteinase Reactions  To
determine whether the exosite interactions affect the initial docking step of the inhibitory mechanism, stopped-flow fluorimetry was employed to monitor the association of PAI-1 with target proteinases by displacement of the active-site titrant, PAB. This method has been used in previous studies to determine directly the second-order association rate constant between PAI-1 and various proteinases, such as tPA, uPA and β-trypsin (21). Figure 2 shows the linear dependence of k obs on the effective concentrations of PAI-1 for the three proteinases, and the calculated rate constants are reported in Table 2 . Among the exosite mutants that were evaluated, E350A/E351A showed a significant (13.4-fold) reduction in k assoc for tPA compared to wtPAI-1 (Figure 2A ), whereas E350A and E351A showed smaller reductions in k assoc (3.3-fold and 5.4-fold, respectively). As observed for the overall proteinase inhibition, the changes in k assoc values for uPA and β-trypsin were small and indistinguishable, respectively, in comparison to control wtPAI-1 reactions ( Figures 2B and 2C) . Notably, the reaction of uPA with the E350A and E350A/E351A variants decreased k assoc by ~50%. The lack of effect on k assoc for β-trypsin with all exosite mutants ( Table 2) is not surprising given the fact that β-trypsin does not have a potential exosite or VR1 analogous to that of tPA or uPA (13) . The role of exosite interactions between the negatively charged distal RCL of PAI-1 and the positively charged VR1 of tPA in the initial fast phase of the serpin reaction has been merely suggested in previous studies (16, 30) . Here, we directly demonstrate the significance of exosite interactions on the initial docking step between PAI-1 and its target proteinases, tPA and uPA. In addition, the k assoc values (Table   2) for the binding of all exosite mutants and wtPAI-1 with the different proteinases are in close agreement with the k app values (Table 1) determined from the loss of enzymatic activity. This indicates that the variations in the inhibitory reaction rates of different proteinases are tightly coupled to the rate constants for non-covalent Michaelis complex formation.
Characterization of the NBD-Labeled Exosite Mutant  We have used a derivative of PAI-1 with an NBD label at the P9 residue (i.e., P9-NBD) in which the emission changes are due to insertion of the reactive center loop after cleavage by the target proteinase. In previous studies, the interaction of P9-NBD PAI-1 with tPA or uPA resulted in significant 13-nm blue shifts in the emission spectrum and ~6-fold enhancements in fluorescence (27) . To determine whether the removal of negatively charged side chains at the P4' and P5' residues affects the spectral changes associated with target proteinase binding, the emission spectra of the NBDlabeled double exosite mutant (E350A/E351A/P9-NBD) were collected in the presence of tPA or uPA. As indicated in Figure 3 , the emission spectra of the PAI-1 mutant showed a broad peak at 12 8-fold increase in the emission intensity. To determine if such spectral changes were due to loop insertion, the emission spectra were obtained after addition of catalytic amounts of elastase. The interaction of the elastase with PAI-1 results in a cleavage of P3-P4 peptide bond of the RCL, followed by insertion of the loop into β-sheet A without trapping elastase in a covalent complex (29) . After cleavage, the emission spectrum of E350A/E351A/P9-NBD showed a 15-nm blue shift and ~8-fold enhancement in fluorescence, similar to the changes caused by tPA or uPA.
The spectral changes of P9-NBD PAI-1 in the presence of various proteinases were comparable to those of previous studies (27) , although those fluorescence enhancements were ~1.4-fold greater than E350A/E351A/P9-NBD (data not shown). Thus, the removal of exosite residues did not significantly alter the ability of the PAI-1 mutant to insert its loop into β-sheet A. was observed. This k lim value reflects the limiting rate for the overall reaction depicted in Scheme 1. As demonstrated in previous studies, the inhibitory activity of P9-NBD PAI-1 is essentially identical to that of native unlabeled wtPAI-1 (20, 21, 27, 31) . In general, the reactions of P9-NBD and exosite variants (E350A/P9-NBD, E351A/P9-NBD, and E350A/E351A/P9-NBD) with tPA, uPA, or β-trypsin resulted in fluorescence changes that fit well to a double exponential function. Figure 4 shows the hyperbolic dependence of k obs on tPA concentration, yielding limiting rate constants for RCL insertion (k lim ) that are increased by 3.7-fold and 3.3-fold, respectively, in E351A and E350A/E351A variants compared to wtPAI-1 (Table 3 ). In contrast, the E350A mutation did not affect the loop insertion rate. As observed 13 for the determination of k app , all exosite substitutions did not dramatically alter the k lim for the inhibition of uPA and β-trypsin (Table 3) . This is consistent with the previous observations that the limiting rate constant for loop insertion, and hence inhibitory activity of PAI-1, are dependent on the specific target proteinase (10, (20) (21) (22) . The effect of the E350A/E51A substitution on k lim also parallels the change observed in the K M for tPA (i.e., ~5-fold increase in K M compared to that of wtPAI-1). This suggests that the relative binding affinity between PAI-1 and the proteinase is of critical importance in controlling the reaction rates of the serpin mechanism, and hence the specificity constant for proteinase inhibition, k lim /K M or k app . It is generally believed that the energy required to move the covalently bound proteinase to the bottom of the serpin molecule is derived from the favorable energy associated with the insertion of the RCL into β-sheet A (32). The observed faster k lim with β-trypsin and uPA (Table 3) are, in fact, due to more favorable free energies of activation compared to those of tPA:PAI-1 reactions (Table 4) .
Effects of Exosite Mutations on the Limiting Rate Constants for Loop Insertion
Alanine substitutions at the P4' and P5' residues of the distal RCL resulted in a nearly 1 kcal/mol decrease in ∆G ≠ (Table 4) , enhancing the rate of loop insertion in the E350A/E351A variant (Table 3) . This is presumably due to the lowering of the energy barrier (i.e., k 3 /k -3 ) that would otherwise impede the release of the primed side of RCL from the active-site pocket of tPA.
Effects of Exosite Substitution on the Limiting Rate Constant for Final Complex
Formation  The formation of the inhibited serpin-proteinase complex was monitored by a rapid acid quenching experiment. This technique protonates the His-57 of the catalytic triad and rapidly traps the covalent serpin-proteinase complex as the acyl-enzyme intermediate (20) . In previous studies, the formation of the final tPA•wtPAI-1 complex resulted in a limiting rate constant (3.3 s -1 ) that was almost identical to the k lim for RCL insertion, as monitored by NBD fluorescence change (Table 3 ) (20) . Figure 5 shows the time course of final complex formation between E350A/E351A and tPA, which is essentially complete within 0.6 sec. The limiting rate value described by the rapid quench data (11.4 s -1 ) was comparable to the limiting rate observed in the fluorescence measurements (11.1 s -1 ), indicating that RCL insertion directly reports the trapping of tPA in a stable acyl-enzyme complex. This further suggests that both processes, loop insertion and serpin-proteinase complex formation, are limited by the same mechanistic step (20, 21) .
DISCUSSION
Although previous studies have shown the significance of the positively charged residues on the VR1 of tPA (14-17), little is known about the specific steps affected by the negatively charged residues on the distal reactive loop of PAI-1. In the present studies, we demonstrate the critical role of the P4' and P5' residues in facilitating the formation of a non-covalent Michaelis complex and controlling the subsequent steps of the PAI-1 inhibitory mechanism. The formation of a final acyl-enzyme complex through loop insertion and the concomitant translocation of the tethered proteinase are intimately linked to the exosite interactions. These molecular events require that bonds, which are initially formed between the proteinase and PAI-1, be broken before the reaction can proceed in the forward direction (20) . Thus, the energy barrier associated with the final complex formation and the distortion of the proteinase is affected by the initial interaction between the VR1 of the proteinase and the distal reactive loop of PAI-1.
The primary effect of the E350A/E351A substitution was a decrease in k assoc (or k 1 in The substitutions at the P4' and P5' residues of PAI-1 had a small effect on the serpin mechanism with uPA and none with β-trypsin. In uPA, the amino acid sequence analogous to the VR1 of tPA contains only three of the four positively charged residues (RRHRGGSVT) that were shown to be of functional significance in tPA ( Figure 6 ) (16, 17) . Based on an earlier modeling study that employed the crystal structure of the trypsin-BPTI complex, Arg-304 of tPA was proposed to form a salt bridge interaction with Glu-350 (P4') of PAI-1. The corresponding residue in uPA is the neutral threonine, which would make such an interaction unlikely.
However, there may be other basic residues in uPA that can contribute to the overall electrostatic field, and thus enable PAI-1 to bind, albeit at a slower rate than that of tPA (Table 2 ). In the uPA:PAI-1 reaction, the weaker electrostatic interaction at the exosite interface would account for the smaller rate constant for the inhibition (k app ) of the proteinase (Table 1 ) and the lower k assoc value (Table 2) , but faster and more favorable loop insertion rate (k lim ) (Tables 3 and 4 ).
The k assoc and k app for β-trypsin are approximately an order of magnitude lower than those of the plasminogen activators, presumably due to the absence of exosite interactions with PAI-1 (17, 30). Loop insertion can proceed with relative ease (Table 3) since there is little, if any, interaction between the proteinase and the distal loop. The kinetic rate constants determined from the present studies are insensitive to either single or double mutations at the distal loop residues of PAI-1 (Tables 1-4 ). This is not surprising given the broad specificity of β-trypsin and the different kinetic step affected by this proteinase, which in this case is the acylation step (k 2 /k -2 ) since k 3 >>k -2 (Scheme 1) (21) . In contrast, the rate-limiting step for the reaction of PAI-1 with tPA or uPA is the release of the distal part of the RCL from the active-site pocket of the target proteinase (k 3 /k -3 ) (18, 23).
As mentioned earlier, the model derived from the crystal structure of a non-covalent trypsin-BPTI complex predicts that the salt bridge interaction between Arg-304 of tPA and Glu-350 of PAI-1 confers specificity to tPA (15) (16) (17) , uPA (33) , and thrombin (34) . Stepwise mutations of the VR1 of tPA have shown the importance of Arg residues for tPA activity and formation of tPA•PAI-1 complexes (16) . Similar studies on the complementary residues of the distal RCL (i.e., Glu-350, Glu-351, and Asp-355) have been rather limited. In one study, the importance of these residues in PAI-1 was evaluated by the reversal of side chains of Glu to those of Arg (17). These mutations resulted in minimal inhibition of tPA (i.e., decrease of 1 order of magnitude compared to the native interaction) by PAI-1. The D355R variant, however, was completely inactive against uPA and tPA. Interestingly, the charge reversal on tPA (i.e., R304E) had a more pronounced effect than the charge reversal on PAI-1, decreasing the secondorder rate constant for proteinase inhibition by 2 orders of magnitude (17).
Our study with single exosite mutants allows us to discuss the contribution, if any, of each residue to the inhibitory mechanism. The removal of negatively charged side chains had the greatest effect with the P5' residue (Glu-351), which decreased the rate constant for (k app ) for the single exosite variants ( Table 1 ). The k lim in E351A variant was increased by 3.7-fold, while that of E350A variant was essentially indistinguishable from the k lim of wtPAI-1 (Table 3 ). This suggests that the contribution of Glu-351 to the exosite interactions appears to be greater than that of Glu-350. The effects of alanine substitution at the P5' position (i.e., E351A)
were similar to those of double mutations in that a significant reduction in k assoc resulted in a loop insertion rate that was modestly enhanced in comparison to wtPAI-1. Thus, the P5' residue plays a critical role in the initial binding interaction with tPA and, as a result of the tight binding interaction, the subsequent insertion of the cleaved RCL into β-sheet A.
Although the exosite interactions are limited with uPA, the individual mutations at the P4' and P5' residues of PAI-1 suggest a slightly different contribution to the serpin mechanism.
For instance, the E351A substitution had a negligible effect on the initial binding interaction with uPA (Table 2) but caused an approximately 40% increase in loop insertion rate (Table 3) compared to wtPAI-1. In contrast, the E350A substitution decreased the k assoc value by 2-fold and yet had no effect on the k lim . In view of these results, Glu-350 appears to play an important role in the formation of the initial complex with uPA, but this interaction may not persist in the final Michaelis complex since the release of the P' side of the distal reactive loop from the active-site pocket of the proteinase is still retarded in a manner similar to wtPAI-1.
Alternatively, the release of residue(s) adjacent to P1' is probably restricted by other interactions within the active site.
Our kinetic results warrant a closer inspection of the residues that have been implicated in the initial tPA•PAI-1 complex. A model of a potential Michaelis complex between PAI-1 and tPA was constructed by using the crystal structure of the non-covalent Manduca sexta serpin 1B-trypsin complex (PDB 1K9O) (35) . The catalytic domain of tPA (PDB 1A5H) and the active structure of PAI-1 (PDB 1B3K) were modeled onto the structure of Manduca sexta serpin 1B-trypsin complex and energy minimized within a 10 Å radius of selected residues at the exosite interface (18, 36) . On the basis of the structural alignment, the RCLs of the Manduca serpin and active PAI-1 share only a 14% sequence homology (35) . The model shown on Figure 7A and q 2 are electronic charges separated by a distance r, and ε is dielectric constant) (38) .
Alternatively, the formation of the non-covalent Michaelis complex is accompanied by conformational changes involving the side chains of both distal loop residues of the serpin and the VR1 of the proteinase (39, 40) . Clearly, the removal of both glutamate side chains would perturb the initial binding interaction between PAI-1 and tPA, which in turn lowers the activation 19 energy necessary to displace the distal primed residues (P1'-P3') of PAI-1 from the active-site pocket.
The binding of the distal reactive loop (Glu-350 and Glu-351) of PAI-1 to theVR1 of tPA appears to have a significant effect on the rate constant of association, and ultimately, the rate constant of inhibition (39) . The significance of theVR1 loop of tPA in conferring PAI-1 specificity has been extensively described by , and more recently by Dekker et al. (39) when the native VR1 of thrombin was replaced with that of tPA.
Thrombin, which has a catalytic domain homologous to that of tPA, is inhibited by PAI-1 at a much slower rate (~4 orders of magnitude lower) than tPA (41). Incorporation of the tPA VR1
increased the rate of thrombin inhibition by PAI-1 from 10 3 M -1 s -1 to 10 6 M -1 s -1 , while only a modest effect on the association rate constant was observed in thrombin-VR1 tPA via surface plasmon resonance (39) . In the present studies, we provide the first kinetic evidence that the exosite interactions between the positively charged surface-exposed VR1 of tPA with the negatively charged side chains of distal RCL of PAI-1 are critical to the initial step of the serpin mechanism, namely the formation of non-covalent Michaelis complex (tPA•PAI-1). An important consequence of this step is an increased rate constant of tPA inhibition that is an order of magnitude higher than other serine proteinases, including thrombin with improved PAI-1 specificity (i.e., thrombin-VR1 tPA ) (39) . Analysis of the successive mutations of the P4' and P5' residues of PAI-1 by double mutant cycle (42) indicates that the changes in the association rate constants (k assoc ) are independent of each other. Thus, the distal RCL residues of PAI-1 have additive effects on the Michaelis complex formation, promoting the productive binding of the cleavage site (i.e., Arg-346-Met-347 peptide bond) at the active-site pocket of tPA.
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Despite the positive contributions of the P4' and P5' residues to the formation of the noncovalent Michaelis complex, the modest effects of the substitutions at these residues on the k lim value suggest that the burial of the RCL into β-sheet A might be restricted by other interactions, such as the hydrogen-bond networks that accompany β-sheet expansion and the steric hindrance imposed by helix F during loop insertion (23, 32) . Thus, other interactions cannot be ruled out in the initial step of the serpin mechanism. Perhaps, another charged residue within the distal RCL, Procedures. The recovered rate constants are reported in Table 3 . 
